Proteina Co., Ltd. (KOSDAQ:468530)

Market Cap	435.34B +20.2%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	11.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	94,206
Open	41,400
Previous Close	39,450
Day's Range	39,500 - 41,800
52-Week Range	15,500 - 120,100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Proteina

Proteina Co., Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information. Proteina Co., Ltd. was founded in 20...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 468530

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 22, 2026

Data Sources Report a data error